Gleevec Shows Promise Against Kaposi’s Sarcoma
Study Findings:
Gleevec (imatinib) has shown promising activity in AIDS-related Kaposi’s sarcoma.
The drug inhibits pathways that spur cancer growth, which led to regression of tumors in five patients within four weeks, the study said. With the other five patients, the disease stabilized and they didn’t develop any new tumors.
“Imatinib is a targeted therapy originally shown to […]